Business briefs, December 24
Target Corp. breach affects 1.2 million accounts connected to sales in NC
DURHAM – Of the Target Corp. customers whose debit or credit card information may have been accessed in a recent data breach, more than 1.2 million shopped at North Carolina stores.
That’s according to information reported by the company and made available by the N.C. Attorney’ General’s Office.
Target reported that it could not determine, however, how many of the more than 1.2 million accounts were owned by residents of the state.
Instead, it reported the number of impacted accounts that were connected to transactions carried out in Target stores in the state.
According to the company, aout 40 million debit and credit card accounts may have been accessed in an unauthorized access of data between Nov. 27 and Dec. 15. The company has begun reaching out to customers who shopped in stores between those dates to alert them of the breach.
The company is also partnering with a third-part forensics firm to investigate the incident, and has alerted authorities and financial institutions.
FHI 360 receives research award for HIV trials work
DURHAM -- FHI 360, a Durham-based nonprofit that has a history in HIV prevention research, has received a seven-year award to continue to serve as the scientific manager for a clinical trials network of investigators, ethicists and others partnering to develop and test HIV prevention tools.
The award is part of a multimillion-dollar grant to the HIV Prevention Trials Network to identify strategies that will reduce HIV transmission in severely impacted populations.
This research grant was awarded to FHI 360 as the “leadership and operations center.” It was made through a collaborative agreement from the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health.
The award is for work including the review of research concepts, protocol development and implementation in the field, network budget and governance, communications and management of network committees.
Durham-Chapel Hill foreclosure rates down in October
Foreclosure rates in the Durham-Chapel Hill area were down year-over-year in October, according to newly released data from the information, analytics and services provider CoreLogic.
The rate of foreclosures among outstanding mortgage loans for the area was 0.92 percent for October 2013, a decrease of 0.50 percentage points compared to October 2012.
Foreclosure activity in Durham-Chapel Hill was lower than the national foreclosure rate, which was 2.15 percent for October.
Also in Durham-Chapel Hill, the mortgage delinquency rate was down. According to the CoreLogic data, 3.59 percent of mortgage loans were 90 days or more delinquent compared to 4.48 percent for the same period last year.
BioCryst files for drug approval
DURHAM – BioCryst Pharmaceuticals has filed for approval for peramivir, an intravenuous flu treatment candidate.
Last year, the company suspended enrollment in a clinical trial for the candidate after an independent analysis of testing the drug in patients in the hospital with serious flu found the drug was "trending toward futility."
The company got a stop-work order for peramivir from the U.S. Department of Health and Human Services except for certain activities.
But in April of this year, BioCryst Pharmaceuticals says it has received a letter from the U.S. Food and Drug Administration outlining a way it could file for regulatory approval of its antiviral drug candidate.